Susceptibility of human herpesvirus 6 to antivirals in vitro

William H. Burns, Gordon R. Sandford

Research output: Contribution to journalArticlepeer-review


Human herpesvirus 6 (HHV–6) is a recently recognized human herpesvirus isolated from lymphoid cells and thought to be the causative agent for exanthem subitum. Using dot blot hybridization, the HHV-6 sensitivity pattern to several antivirals was compared with those of herpes simplex virus type 1 and human cytomegalovirus. HHV–6 most closely resembled cytomegalovirus in that it was relatively resistant to the antiviral effects of acyclovir and bromovinyl-deoxyuridine but sensitive to ganciclovir and phosphonoacetic acid. From these results, it appears more likely that HHV–6 infections would respond to ganciclovir and foscarnet than to acyclovir should treatment deemed be advisable, although the low toxicity of acyclovir may allow for its use at doses that might affect replication of HHV–6.

Original languageEnglish (US)
Pages (from-to)634-637
Number of pages4
JournalJournal of Infectious Diseases
Issue number3
StatePublished - Sep 1990
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Susceptibility of human herpesvirus 6 to antivirals in vitro'. Together they form a unique fingerprint.

Cite this